News und Analysen
UnitedHealth Group Just Released More Bad News. Should You Avoid the Stock?
Things are going from bad to worse for UnitedHealth Group (NYSE: UNH). Investors were already enduring a tough year in 2025, with the company facing myriad bits of bad news, including poor financial
Ardelyx Q2 Revenue Jumps 33%
Ardelyx (NASDAQ:ARDX), a biopharmaceutical company focused on gastrointestinal and cardiorenal therapeutics, reported its second quarter 2025 earnings on August 4, 2025. The headline news was a
Cathie Wood Goes Shopping: 3 Stocks She Just Bought
Cathie Wood is on a roll. The co-founder, CEO, and chief investment officer of Ark Invest is at her best when growth stocks are rallying, and that's the case right now. Her largest exchange-traded
Southern Company Boosts Capital Plan
Southern Company (NYSE:SO) reported its second quarter 2025 earnings on July 31, 2025, announcing a $13 billion increase in its five-year base capital plan to $76 billion. The company highlighted
GBTG Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, Aug. 5, 2025 at 1:00 p.m. ET
Chief Executive Officer — Paul Abbott
Source Fool.com
Should You Buy AMD Stock Before Wednesday?
In this video, I will explain everything you need to know about Advanced Micro Devices (NASDAQ: AMD) before the company reports earnings on Tuesday after the market closes. Watch the short video to
If You'd Invested $1,000 in PFE 5 Years Ago, Here's How Much You'd Have Today
Five years ago, the world was in the thick of the COVID-19 global pandemic, bringing Pfizer (NYSE: PFE) into the spotlight because of the role it played in developing the COVID-19 vaccine with its
1 Top Dividend Growth Stock to Buy and Hold Forever
There are many reasons to invest in dividend stocks. Companies that offer regular payouts tend to have strong underlying operations and generate consistent revenue and profits, making them excellent
Up 50% in 3 Months, Is This Stock Still a Buy?
Is this finally the year CRISPR Therapeutics (NASDAQ: CRSP) bounces back? The biotech has lagged the market in recent years, but shares are up 50% over the past three months and have climbed 42%
HealthStream (HSTM) Q2 Revenue Up 4%
HealthStream (NASDAQ:HSTM), a leading provider of healthcare workforce and training solutions, reported its results on August 4, 2025, for the fiscal second quarter ended June 30, 2025. The most
Syndax (SNDX) Q2 Revenue Jumps 986%
Syndax Pharmaceuticals (NASDAQ:SNDX), a biopharmaceutical company specializing in oncology therapeutics, reported its second-quarter 2025 earnings on August 4, 2025. The most notable news was its
Why Shares of Rigetti Computing Are Soaring Today
Shares of Rigetti Computing (NASDAQ: RGTI) traded nearly 10% higher, as of 10:49 a.m. ET today, after a Wall Street analyst raised his price target on the stock and reiterated a buy rating on the
EQS-News: Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
EQS-Adhoc: Gerresheimer AG to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
Should You Buy AMD Stock Before August 5?
In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.
Praxis (PRAX) Q2 Loss Widens 90%
Praxis Precision Medicines (NASDAQ:PRAX) is a clinical-stage biopharmaceutical company specializing in therapies for central nervous system (CNS) disorders. On August 4, 2025, it reported financial
Axsome (AXSM) Q2 Revenue Soars 72%
Axsome Therapeutics (NASDAQ:AXSM), a biopharmaceutical company focused on central nervous system (CNS) disorders, released its earnings on August 4, 2025. The company reported GAAP revenue of $150.0
If You'd Invested $1,000 in Medtronic (MDT) Stock 5 Years Ago, Here's How Much You'd Have Today
What were you doing five years ago? Were you working from home due to the new pandemic? Watching Shakira and J. Lo perform at the Super Bowl? Perhaps you were buying some stocks. If you spent $1,000
This Biotech Stock Could Soar on Upcoming Clinical Data
While most investors pile into Eli Lilly (NYSE: LLY) or flee from struggling Novo Nordisk (NYSE: NVO), they're missing a compelling opportunity in the clinical-stage space. Novo recently lost nearly
Waters (WAT) Q2 Revenue Jumps 9%
Waters (NYSE:WAT), the analytical instruments and laboratory technology leader, released its Q2 2025 earnings on August 4, 2025. The company's results topped Wall Street estimates, reporting revenue
EQS-News: Biotest AG receives a request from Grifols S.A. to convene an extraordinary general meeting
1 Dividend Champion Stock Beating the Market in 2025
Dividend Champions are an elite group of stocks that have increased their dividend payments for more than 25 consecutive years.
Blue chip dividend growth stocks with these lengthy track records are
2 Beaten-Down Stocks With Incredible Upside Potential
Recent history has, once again, demonstrated that relatively small biotech companies can see their shares soar significantly on positive developments. Summit Therapeutics' stock is up by more than
If You'd Invested $1,000 in AbbVie (ABBV) Stock 10 Years Ago, Here's How Much You'd Have Today
Think back to 10 years ago. The New England Patriots and their quarterback Tom Brady were accused of underinflating footballs. The Supreme Court affirmed same-sex marriage nationwide. And Apple
The 3 Things That Matter for Pfizer Now
Once a market darling during the early pandemic years, Pfizer (NYSE: PFE) has been on a straight southbound path for several years now. The company's shares are down by 50% since 2022.
Some